Targeting cadherin-17 inactivates Wnt signaling and inhibits tumor growth in liver carcinoma

Ling Xiao Liu, Nikki P. Lee, Vivian W. Chan, Wen Xue, Lars Zender, Chunsheng Zhang, Mao Mao, Hongyue Dai, Xiao Lin Wang, Michelle Z. Xu, Kin Wah Lee, Irene O. Ng, Yangchao Chen, Hsiang Fu Kung, Scott W. Lowe, Ronnie T.P. Poon, Jian Hua Wang, John M. Luk

Research output: Journal article publicationJournal articleAcademic researchpeer-review

95 Citations (Scopus)

Abstract

Hepatocellular carcinoma (HCC) is a lethal malignancy for which there are no effective therapies. To develop rational therapeutic approaches for treating this disease, we are performing proof-of-principle studies targeting molecules crucial for the development of HCC. Here, we show that cadherin-17 (CDH17) adhesion molecule is up-regulated in human liver cancers and can transform premalignant liver progenitor cells to produce liver carcinomas in mice. RNA interference-mediated knockdown of CDH17 inhibited proliferation of both primary and highly metastatic HCC cell lines in vitro and in vivo. The antitumor mechanisms underlying CDH17 inhibition involve inactivation of Wnt signaling, because growth inhibition and cell death were accompanied by relocalization of β-catenin to the cytoplasm and a concomitant reduction in cyclin D1 and an increase in retinoblastoma. Conclusion: Our results identify CDH17 as a novel oncogene in HCC and suggest that CDH17 is a biomarker and attractive therapeutic target for this aggressive malignancy.
Original languageEnglish
Pages (from-to)1453-1463
Number of pages11
JournalHepatology
Volume50
Issue number5
DOIs
Publication statusPublished - 1 Dec 2009
Externally publishedYes

ASJC Scopus subject areas

  • Hepatology

Cite this